NITISINONE
nitisinone 10 mg capsule, 60
NITISINONE (15467C)
15467C
Manner of administration:Oral
Restriction
Indication: Hereditary tyrosinaemia type 1 (HT-1)
Treatment phase: Initial treatment
Restriction
Indication: Hereditary tyrosinaemia type 1 (HT-1)
Treatment phase: Grandfather arrangement (transition from LSDP-funded Hereditary Tyrosinaemia type
1 therapy)
Restriction
Indication: Hereditary tyrosinaemia type 1 (HT-1)
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 5 | DPMQ: $3,995.62 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Orfadin | |||||